CAS Medical Systems, Inc.
CASM
CASM was delisted on the 18th of April, 2019.
19 hedge funds and large institutions have $15.3M invested in CAS Medical Systems, Inc. in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 5 closing their positions.
6% less capital invested
Capital invested by funds: $16.2M → $15.3M (-$920K)
14% less funds holding
Funds holding: 22 → 19 (-3)
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$598K |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$38.7K |
| 3 |
Renaissance Technologies
New York
|
+$13.4K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$7.99K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$2.48K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
-$432K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$60K |
| 3 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
-$35K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$33.5K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$19K |
CASM Hedge Fund Activity: Q3 2016 in Review
19 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in CAS Medical Systems, Inc. (CASM) for Q3 2016, worth a combined $15.3M — down 5.7% from $16.2M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of CASM and 2 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 3 added.
The largest buyer was Acuta Capital Partners, adding an estimated $598K. The largest seller was Broadfin Capital, cutting an estimated $432K.
- 19 institutional investors held CAS Medical Systems, Inc. (CASM) as of Q3 2016, down from 22 in Q2 2016.
- Funds reported $15.3M of CAS Medical Systems, Inc. stock for Q3 2016, down 5.7% quarter-over-quarter.
- 2 funds opened new CAS Medical Systems, Inc. positions in Q3 2016 and 5 closed out, a net change of -3 holders.
- The largest CAS Medical Systems, Inc. buyer in Q3 2016 was Acuta Capital Partners, an estimated $598K added.
- The largest CAS Medical Systems, Inc. seller in Q3 2016 was Broadfin Capital, an estimated $432K sold.
Based on aggregated 13F filings for Q3 2016.